6.200
+1,64%
2026-10-19
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +35.9% | +174.2% | 3 / 3 | +21.6% | +9.04 pp | +1.44 pp | +2.3% | 0.00 | 25.50 | 17,1 | +21,6% | 2,3 | +35,9% | 25.50 | 26.96 | −5,4% |
| Pts | 8 | 12 | 12 | 12 | 12 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 6.200 (close price on 2026-10-19)EPS (TTM): 243,2
Financial charts
1.Revenue & growth
VND bn16,8Q2/26
1.Revenue & growth
VND bn16,8Q2/26
2.Profit & growth
VND bn0,60Q2/26
3.Profit mix (Penman)
VND bn2,10Q2/26
4.Margins & cost structure
%20.9%Q2/26
5.Returns & cash cycle
% · days-0.1%Q2/26
6.Earnings quality & cash
VND bn11,3Q2/26
7.Asset structure
VND bn149Q2/26
8.Funding & debt health
VND bn · times149Q2/26
9.Revenue backlog
VND bn0,45Q2/26
10.Valuation
times · %52,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %44Q2/26
Adjusted EPS growth, latest quarter
-64.8%
Average adjusted EPS growth, 3 quarters
-64.8%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26